Survey of the management of patients with bronchiectasis: a pilot investigation in Asian populations
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Although international guidelines for bronchiectasis management have been published in Western countries, there is a lack of data about their application in Asian populations including patients with different phenotypes. We aimed to investigate the current status of bronchiectasis management in Asian populations. Methods: A nationwide questionnaire survey was performed of Asian respiratory specialists from South Korea, Japan, Taiwan, Singapore, Vietnam, and Sri Lanka. Participants were invited by e-mail to answer a questionnaire comprising 25 questions based on international guidelines for the management of bronchiectasis. Results: A total of 221 physicians participated in the survey. About half of them were Korean (50.2%), with the next most common nationalities being Japanese (23.1%), Taiwanese (13.6%), and Singaporean (7.7%). Only 18 (8.1%) responders had local guidelines for bronchiectasis. While 85 (38.5%) responders checked sputum acid-fast bacillus smear/culture about 1 to 3 times per year, only a small proportion of responders routinely performed a serum immunoglobulin test (36/221, 16.3%) or evaluated for allergic bronchopulmonary aspergillosis (41/221, 18.6%). Less than half (43.4%) of responders performed eradication treatment in patients with drug-sensitive Pseudomonas aeruginosa infection, mainly due to the limited availability of inhaled antibiotics (34.8%). In addition, 58.6% of responders considered physiotherapy such as airway clearance and pulmonary rehabilitation. Conclusions: Discrepancies might exist between guideline recommendations and practice for bronchiectasis management in Asian populations, partly due to the limited availability of treatment in each country. The development of local guidelines that consider the phenotypes and situation will help to standardize and improve the management of bronchiectasis.
Abstract
Background/Aims: Although international guidelines for bronchiectasis management have been published in Western countries, there is a lack of data about their application in Asian populations including patients with different phenotypes. We aimed to investigate the current status of bronchiectasis management in Asian populations. Methods: A nationwide questionnaire survey was performed of Asian respiratory specialists from South Korea, Japan, Taiwan, Singapore, Vietnam, and Sri Lanka. Participants were invited by e-mail to answer a questionnaire comprising 25 questions based on international guidelines for the management of bronchiectasis. Results: A total of 221 physicians participated in the survey. About half of them were Korean (50.2%), with the next most common nationalities being Japanese (23.1%), Taiwanese (13.6%), and Singaporean (7.7%). Only 18 (8.1%) responders had local guidelines for bronchiectasis. While 85 (38.5%) responders checked sputum acid-fast bacillus smear/culture about 1 to 3 times per year, only a small proportion of responders routinely performed a serum immunoglobulin test (36/221, 16.3%) or evaluated for allergic bronchopulmonary aspergillosis (41/221, 18.6%). Less than half (43.4%) of responders performed eradication treatment in patients with drug-sensitive Pseudomonas aeruginosa infection, mainly due to the limited availability of inhaled antibiotics (34.8%). In addition, 58.6% of responders considered physiotherapy such as airway clearance and pulmonary rehabilitation. Conclusions: Discrepancies might exist between guideline recommendations and practice for bronchiectasis management in Asian populations, partly due to the limited availability of treatment in each country. The development of local guidelines that consider the phenotypes and situation will help to standardize and improve the management of bronchiectasis.
참고문헌 (33)
- Barker AF, "Bronchiectasis", N Engl J Med, 346, pp.1383~1393 (2002)
- King PT, "Characterisation of the onset and presenting clinical features of adult bronchiectasis", Respir Med, 100, pp.2183~2189 (2006)
- Hill AT, "Pulmonary exacerbation in adults with bronchiectasis : a consensus definition for clinical research", Eur Respir J, 49, pp.1700051~ (2017)
- Goeminne PC, "The economic burden of bronchiectasis: known and unknown. A systematic review", BMC Pulm Med, 19, pp.54~ (2019)
- de la Rosa Carrillo D, "Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis", Respiration, 96, pp.406~416 (2018)
- Ringshausen FC, "Increasing bronchiectasis prevalence in Germany, 2009-2017 : a population-based cohort study", Eur Respir J, 54, pp.1900499~ (2019)
- Chalmers JD, "New insights into the epidemiology of bronchiectasis", Chest, 154, pp.1272~1273 (2018)
- Martinez-Garcia MA, "Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults", Arch Bronconeumol, 54, pp.79~87 (2018)
- Hill AT, "British Thoracic Society guideline for bronchiectasis in adults", Thorax, 74(Suppl 1), pp.1~69 (2019)
- Polverino E, "European Respiratory Society guidelines for the management of adult bronchiectasis", Eur Respir J, 50, pp.1700629~ (2017)
- Al-Jahdali H, "The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis", Ann Thorac Med, 12, pp.135~161 (2017)
- Chalmers JD, "Bronchiectasis : new therapies and new perspectives", Lancet Respir Med, 6, pp.715~726 (2018)
- Dhar R, "Bronchiectasis in India : results from the European Multicentre Bronchiectasis Audit and Research Collaboration(EMBARC)and Respiratory Research Network of India Registry", Lancet Glob Health, 7, pp.e1269~e1279 (2019)
- Choi H, "Population-based prevalence of bronchiectasis and associated comorbidities in South Korea", Eur Respir J, 54, pp.1900194~ (2019)
- Huang HY, "Etiology and characteristics of patients with bronchiectasis in Taiwan : a cohort study from 2002 to 2016", BMC Pulm Med, 20, pp.45~ (2020)
- Visser SK, "Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?", Lung, 197, pp.803~810 (2019)
- Martinez-Garcia MA, "Spanish guidelines on treatment of bronchiectasis in adults", Arch Bronconeumol, 54, pp.88~98 (2018)
- Gao YH, "Aetiology of bronchiectasis in adults : a systematic literature review", Respirology, 21, pp.1376~1383 (2016)
- Shoemark A, "Aetiology in adult patients with bronchiectasis", Respir Med, 101, pp.1163~1170 (2007)
- Pasteur MC, "An investigation into causative factors in patients with bronchiectasis", Am J Respir Crit Care Med, 162(4 Pt 1), pp.1277~1284 (2000)
- Guan WJ, "Aetiology of bronchiectasis in Guangzhou, southern China", Respirology, 20, pp.739~748 (2015)
- Kadowaki T, "An analysis of etiology, causal pathogens, imaging patterns, and treatment of Japanese patients with bronchiectasis", Respir Investig, 53, pp.37~44 (2015)
- Park J, "Factors associated with radiologic progression of non-cystic fibrosis bronchiectasis during long-term follow-up", Respirology, 21, pp.1049~1054 (2016)
- Lee H, "Epidemiology of nontuberculous mycobacterial infection, South Korea, 2007-2016", Emerg Infect Dis, 25, pp.569~572 (2019)
- Prevots DR, "Epidemiology of human pulmonary infection with nontuberculous mycobacteria : a review", Clin Chest Med, 36, pp.13~34 (2015)
- Aksamit TR, "Adult patients with bronchiectasis : a first look at the US Bronchiectasis Research Registry", Chest, 151, pp.982~992 (2017)
- 임정우, "Prevalence of Primary Immunodeficiency in Korea", Journal of Korean Medical Science, 27(7), pp.788~793 (2012), 대한의학회[DOI]
- Odnoletkova I, "The burden of common variable immunodeficiency disorders : a retrospective analysis of the European Society for Immunodeficiency(ESID)registry data", Orphanet J Rare Dis, 13, pp.201~ (2018)
- Denning DW, "Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults", Med Mycol, 51, pp.361~370 (2013)
- Orriols R, "Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis", Respiration, 90, pp.299~305 (2015)
- White L, "Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis", Respir Med, 106, pp.356~360 (2012)
- Zanini A, "Effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis : a retrospective analysis of clinical and functional predictors of efficacy", Respiration, 89, pp.525~533 (2015)
- Lee AL, "The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis : a randomised controlled trial", Respir Res, 15, pp.44~ (2014)